Crossmark

In silico bioprospecting of taraxerol as a main protease inhibitor of SARS-CoV-2 to develop therapy against COVID-19

Published Online: 2022-04-28

Published Print: 2022-10

Authors

Mujwar, Somdutt https://orcid.org/0000-0003-4037-5475
Harwansh, Ranjit K.
License Information

Text and Data Mining valid from 2022-04-28

Version of Record valid from 2022-04-28
More Information

Article History

Received: 31 January 2022

Accepted: 13 April 2022

First Online: 28 April 2022

Declarations

:

: The authors declare no competing interests.

Free to read: This content has been made available to all.

Document is current